AusBiotech is pleased to support the next United Kingdom-Australia BioBridge event, taking place on 26 May 2025, which will bring together senior leaders from across the biotechnology, healthcare, and life sciences sectors.
Hosted by the British Consulate-General, the member-only lunch reception will welcome special guest, the UK's Medicines Discovery Catapult Chief Executive Officer Chris Molloy, Chief, alongside industry and policy leaders.
The proposed BioBridge initiative is a strategic collaboration that connects the UK and Australian life sciences ecosystems to foster innovation, commercial partnerships, and trade growth. The event will focus on sharing best practices for accelerating high-value biotech services, identifying opportunities for cross-border collaboration, and supporting bilateral growth in R&D and advanced manufacturing.
The partnership builds on the shared ambition of both countries to lead in life sciences innovation and drive global health outcomes. Events like this create valuable pathways for SMEs, researchers, and investors to explore new markets and strengthen international networks.
AusBiotech proudly champions cross-border connections that grow Australia's life sciences sector and amplify our global impact.
